Physician profile
Eric M Dvorak
NPI 1003986845
$2,982.79
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $906 · 2020: $245 · 2021: $456 · 2022: $566 · 2023: $681 · 2024: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $575 · Travel and Lodging: $234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $575.32 |
| Travel and Lodging | $234.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ipsen Biopharmaceuticals, INC | $606.36 | 2020-2024 | Dysport |
| Allergan, INC. | $400.42 | 2019-2022 | |
| Arthrex, INC. | $385.21 | 2023 | Arthrex |
| Merz North America, INC. | $223.32 | 2019-2020 | |
| Merz Pharmaceuticals, LLC | $216.09 | 2021-2023 | Xeomin |
| Abbvie INC. | $209.39 | 2022-2023 | Botox, Qulipta |
| Piramal Critical Care | $201.26 | 2020-2023 | |
| Novartis Pharmaceuticals Corporation | $145.48 | 2019-2022 | |
| Medtronic USA, INC. | $107.46 | 2019-2020 | |
| Emd Serono, INC. | $84.06 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $49.40 | 2019-2022 | |
| Ge Healthcare | $43.71 | 2019-2022 | |
| Csl Behring | $43.60 | 2019 | |
| Kyowa Kirin, INC. | $40.93 | 2019-2022 | |
| Lundbeck LLC | $31.01 | 2019-2023 | Vyepti |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saol Therapeutics INC. | $30.37 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $27.35 | 2023 | Austedo Xr |
| Biogen, INC. | $19.78 | 2020 | |
| Medtronic, INC. | $18.01 | 2022 | |
| Horizon Therapeutics Plc | $17.01 | 2022 | |
| Tanabe Pharma America, INC. | $15.64 | 2019 | |
| Neurocrine Biosciences, INC. | $14.65 | 2019 | |
| Lilly USA, LLC | $14.41 | 2019 | |
| Sk Life Science, INC. | $13.43 | 2021 | |
| Eisai INC. | $12.24 | 2019 | |
| Acorda Therapeutics, INC | $12.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Dvorak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.